CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 64 enrolled
Drug / intervention
Symfony IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06229106
NCT06229106Phase 4Completed
CompareCT.gov

Evaluation of the Symfony With Optiblue Intraocular Lens Compared to The Vivity IOL Under Mesopic Conditions

Carolina Eyecare Physicians, LLC·interventional·Posted Jan 29, 2024·Updated Feb 14, 2025

In Brief

A Phase 4 clinical trial evaluating Symfony IOL and Vivity IOL for Cataract. Completed, enrolled 64 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract surgery. Participants will be asked to read a visual acuity chart at different distances in dim light.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsScience in Vision

Timeline

Phase 4CompletedFinished
202420252026
First PostedJan 29, 2024
Enrollment StartDec 1, 2023
Primary CompletionOct 30, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 2.4 years ago

Interventions

Symfony IOLdevice

The Symfony IOL is a lens designed to provide high quality vision up tp 26 inches reducing the need for glasses after routine cataract surgery in patients with or without astigmatism.

Vivity IOLdevice

The Vivity IOL is a lens that provides extended range of vision ranging from distance to near reducing the need for glasses after routine cataract surgery in patients with or without astigmatism.